The Institute of Medicine of the National Academy of Sciences has elected 70 new members including Lynda Chin, Stephen Quake, and Daniel Kastner. Chin is currently a professor and chair of genomic medicine and scientific director of the Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center. Quake is a professor of bioengineering at Stanford University and an investigator at the Howard Hughes Medical Institute. Kastner is the scientific director of the National Human Genome Research Institute, where, among other duties, he leads the inflammatory disease section of the medical genetics branch.

Caprotec Bioanalytics has appointed Jonathan Turner to be CEO and managing director. Turner will take over the CEO spot from company founder Hubert Koester, who will continue to work with the company as acting chief scientific officer and chairman of the scientific advisory board. Turner formerly was senior VP at XL Techgroup, a technology developer and equity firm, and he held senior management posts at Boehringer Ingelheim, Astrazeneca, and Schering.

Bill Bowen has been appointed by Sequenom SVP and general counsel. He will report directly to Chairman and CEO Harry Hixson and will be responsible for the company's legal and patent issues. Bowen was previously with Gen-Probe, where he was SVP and general counsel. Before that he was a business litigation partner at Luce Forward Hamilton & Scripps.

View original post here:
Foundation Medicine, AstraZeneca to ID Genetic Mutations for Cancer Drug Development

Comments are closed.